Wave Life Sciences (WVE) News Today $14.45 +1.00 (+7.43%) (As of 12/17/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Wellington Management Group LLP Has $2.59 Million Stock Holdings in Wave Life Sciences Ltd. (NASDAQ:WVE)Wellington Management Group LLP trimmed its stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 26.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 315,502 shares of the company's stock afterDecember 18 at 3:45 AM | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Receives Average Recommendation of "Buy" from BrokeragesShares of Wave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) have been given an average recommendation of "Buy" by the ten analysts that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating, eight have given a buy rating and oDecember 18 at 2:23 AM | marketbeat.comWave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare ConferenceDecember 16 at 8:30 AM | globenewswire.comPoint72 Asset Management L.P. Cuts Stake in Wave Life Sciences Ltd. (NASDAQ:WVE)Point72 Asset Management L.P. cut its holdings in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 75.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 28,096 shares of the company's stock after selDecember 13, 2024 | marketbeat.comBuy Rating for Wave Life Sciences: Favorable Regulatory Environment and Promising WVE-003 DataDecember 12, 2024 | markets.businessinsider.comWave Life Sciences Ltd. (NASDAQ:WVE) Shares Purchased by Fmr LLCFmr LLC lifted its holdings in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 174.5% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,540,190 shares of the company's stock after purchasing an additional 979,110 shares during theDecember 12, 2024 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Shares Purchased by Charles Schwab Investment Management Inc.Charles Schwab Investment Management Inc. grew its holdings in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 209.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 844,617 shares of the company's stock aftDecember 12, 2024 | marketbeat.comJacobs Levy Equity Management Inc. Sells 262,075 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE)Jacobs Levy Equity Management Inc. reduced its holdings in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 71.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 104,526 shares of the company's stockDecember 10, 2024 | marketbeat.comWave Life Sciences: Positioned for Growth with Promising Huntington’s Treatment and Strategic AdvantagesDecember 6, 2024 | markets.businessinsider.comRTW Investments LP Invests $7.38 Million in Wave Life Sciences Ltd. (NASDAQ:WVE)RTW Investments LP bought a new position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 900,000 shares of the company's stock, valued at approxiDecember 5, 2024 | marketbeat.comPolar Asset Management Partners Inc. Takes $3.99 Million Position in Wave Life Sciences Ltd. (NASDAQ:WVE)Polar Asset Management Partners Inc. purchased a new stake in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 486,023 shares of the company's stDecember 5, 2024 | marketbeat.com850,000 Shares in Wave Life Sciences Ltd. (NASDAQ:WVE) Bought by Maven Securities LTDMaven Securities LTD bought a new stake in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 850,000 shares of the company's stock, valued at approximately $6,970,000. WaveDecember 4, 2024 | marketbeat.comCinctive Capital Management LP Purchases 256,146 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE)Cinctive Capital Management LP grew its position in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 255.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 356,308 shares of the company's stock after buyDecember 3, 2024 | marketbeat.com344,063 Shares in Wave Life Sciences Ltd. (NASDAQ:WVE) Bought by Baker BROS. Advisors LPBaker BROS. Advisors LP purchased a new stake in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor purchased 344,063 shares of the company's stock, valued at approximately $2,821,000. Baker BROS. AdviDecember 2, 2024 | marketbeat.com602,441 Shares in Wave Life Sciences Ltd. (NASDAQ:WVE) Acquired by Walleye Capital LLCWalleye Capital LLC bought a new position in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 602,441 shares of the company's stock, valued at approximatDecember 2, 2024 | marketbeat.comInsider Selling: Wave Life Sciences Ltd. (NASDAQ:WVE) CEO Sells 50,000 Shares of StockNovember 28, 2024 | insidertrades.comWave Life Sciences Ltd. (NASDAQ:WVE) Receives Consensus Recommendation of "Buy" from BrokeragesWave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) has received a consensus rating of "Buy" from the ten research firms that are presently covering the company, Marketbeat reports. One research analyst has rated the stock with a hold recommendation, eight have given a buy recommendation and onNovember 23, 2024 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Shares Sold by Primecap Management Co. CAPrimecap Management Co. CA lessened its stake in Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 3.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,580,700 shares of the company's stoNovember 22, 2024 | marketbeat.comWave Life Sciences price target raised to $22 from $19 at MizuhoNovember 21, 2024 | markets.businessinsider.comWave Life Sciences (NASDAQ:WVE) Stock Price Expected to Rise, Mizuho Analyst SaysMizuho upped their price target on Wave Life Sciences from $19.00 to $22.00 and gave the stock an "outperform" rating in a report on Thursday.November 21, 2024 | marketbeat.comWave Life Sciences Advances RNA Medicine InnovationsNovember 21, 2024 | markets.businessinsider.comB. Riley Reduces Earnings Estimates for Wave Life SciencesWave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - B. Riley lowered their FY2024 earnings per share (EPS) estimates for Wave Life Sciences in a research note issued on Wednesday, November 13th. B. Riley analyst M. El-Saadi now anticipates that the company will earn ($1.16) per share for the yeaNovember 18, 2024 | marketbeat.comHC Wainwright Has Negative Estimate for WVE FY2024 EarningsWave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Research analysts at HC Wainwright cut their FY2024 EPS estimates for shares of Wave Life Sciences in a note issued to investors on Wednesday, November 13th. HC Wainwright analyst A. Fein now anticipates that the company will post earnings of (November 18, 2024 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) CEO Sells $733,670.88 in StockWave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) CEO Paul Bolno sold 51,234 shares of Wave Life Sciences stock in a transaction dated Friday, November 15th. The stock was sold at an average price of $14.32, for a total value of $733,670.88. Following the sale, the chief executive officer now directly owns 217,351 shares of the company's stock, valued at approximately $3,112,466.32. This trade represents a 19.08 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.November 15, 2024 | marketbeat.comWave Life Sciences Ltd. (NASDAQ:WVE) Released Earnings Last Week And Analysts Lifted Their Price Target To US$22.20November 15, 2024 | finance.yahoo.comFY2028 EPS Forecast for Wave Life Sciences Lifted by AnalystWave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Research analysts at HC Wainwright boosted their FY2028 earnings per share (EPS) estimates for shares of Wave Life Sciences in a note issued to investors on Wednesday, November 13th. HC Wainwright analyst A. Fein now anticipates that the companNovember 15, 2024 | marketbeat.comWave Life Sciences to Present at Jefferies London Healthcare ConferenceNovember 15, 2024 | globenewswire.comWhat is B. Riley's Estimate for WVE Q1 Earnings?Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Stock analysts at B. Riley issued their Q1 2025 earnings per share (EPS) estimates for shares of Wave Life Sciences in a research note issued on Wednesday, November 13th. B. Riley analyst M. El-Saadi anticipates that the company will post earniNovember 15, 2024 | marketbeat.comEquities Analysts Offer Predictions for WVE FY2024 EarningsWave Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Equities researchers at Leerink Partnrs boosted their FY2024 EPS estimates for shares of Wave Life Sciences in a research report issued to clients and investors on Tuesday, November 12th. Leerink Partnrs analyst J. Schwartz now anticipates thatNovember 15, 2024 | marketbeat.comPositive Outlook for Wave Life Sciences Amid Strategic Advances and Regulatory MilestonesNovember 15, 2024 | markets.businessinsider.comPositive Outlook for Wave Life Sciences: FDA Support and Strategic Positioning Drive Buy RatingNovember 15, 2024 | markets.businessinsider.comInsider Selling: Wave Life Sciences Ltd. (NASDAQ:WVE) Insider Sells 36,000 Shares of StockNovember 14, 2024 | insidertrades.comWave Life Sciences Ltd. (NASDAQ:WVE) Short Interest Up 39.5% in OctoberWave Life Sciences Ltd. (NASDAQ:WVE - Get Free Report) was the target of a significant increase in short interest in October. As of October 31st, there was short interest totalling 6,820,000 shares, an increase of 39.5% from the October 15th total of 4,890,000 shares. Based on an average daily trading volume, of 1,690,000 shares, the days-to-cover ratio is currently 4.0 days.November 14, 2024 | marketbeat.comWave Life Sciences: Promising Advancements and Strategic Growth Potential Drive Buy RatingNovember 13, 2024 | markets.businessinsider.comWave Life Sciences Gains Buy Rating from Andrew Fein Amid Promising Trial Advancements and Potential Accelerated Approval PathwaysNovember 13, 2024 | markets.businessinsider.comWave Life Sciences Ltd. (NASDAQ:WVE) Q3 2024 Earnings Call TranscriptNovember 13, 2024 | msn.comWave Life Sciences' (WVE) Buy Rating Reiterated at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $22.00 price target on shares of Wave Life Sciences in a report on Wednesday.November 13, 2024 | marketbeat.comWAVE Life Sciences Ltd (WVE) Q3 2024: Everything You Need to Know Ahead of EarningsNovember 12, 2024 | finance.yahoo.com48,834 Shares in Wave Life Sciences Ltd. (NASDAQ:WVE) Acquired by Privium Fund Management B.V.Privium Fund Management B.V. bought a new stake in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 48,834 shares of the company's stock, valued at approximatelNovember 10, 2024 | marketbeat.comWave Life Sciences treatment of Huntington’s disease gets FDA orphan designationNovember 9, 2024 | markets.businessinsider.comWave Life Sciences (NASDAQ:WVE) Reaches New 12-Month High - Still a Buy?Wave Life Sciences (NASDAQ:WVE) Reaches New 1-Year High - Still a Buy?November 8, 2024 | marketbeat.comWave Life Sciences (WVE) to Release Earnings on TuesdayWave Life Sciences (NASDAQ:WVE) will be releasing earnings before the market opens on Tuesday, November 12, Zacks reports.November 5, 2024 | marketbeat.comWave Life Sciences price target raised to $22 from $19 at B. RileyNovember 4, 2024 | markets.businessinsider.comB. Riley Increases Wave Life Sciences (NASDAQ:WVE) Price Target to $22.00B. Riley raised their price target on shares of Wave Life Sciences from $19.00 to $22.00 and gave the stock a "buy" rating in a research note on Monday.November 4, 2024 | marketbeat.comEmerald Advisers LLC Acquires 388,280 Shares of Wave Life Sciences Ltd. (NASDAQ:WVE)Emerald Advisers LLC grew its holdings in shares of Wave Life Sciences Ltd. (NASDAQ:WVE - Free Report) by 15.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,881,510 shares of the company's stock after buying aNovember 3, 2024 | marketbeat.comWave Life Sciences: Strategic Advancements and Promising Pipeline Drive Buy RatingNovember 1, 2024 | markets.businessinsider.comBRIEF-Wave Life Sciences Plans To Have Five Galnac-RNA Editing Or GalNAc-siRNA Programs In Clinic By 2026November 1, 2024 | sg.finance.yahoo.comHC Wainwright Reaffirms "Buy" Rating for Wave Life Sciences (NASDAQ:WVE)HC Wainwright reaffirmed a "buy" rating and set a $22.00 price objective on shares of Wave Life Sciences in a report on Thursday.October 31, 2024 | marketbeat.comWave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing ProgramsOctober 30, 2024 | globenewswire.comHow to play biotech stocks: Insmed and Wave Life SciencesOctober 29, 2024 | finance.yahoo.com Get Wave Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter. Email Address Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. WVE Media Mentions By Week WVE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. WVE News Sentiment▼1.440.72▲Average Medical News Sentiment WVE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. WVE Articles This Week▼74▲WVE Articles Average Week Get Wave Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ASND News RVMD News LNTH News NUVL News LEGN News BPMC News ELAN News CYTK News TGTX News VKTX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:WVE) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Wave Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Wave Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free WVE Stock Alerts